Held on 26 October 2016
Bliss GVS Pharma announced that the Board of Directors of the Company at its meeting held on 26 October 2016 have transacted the following -The Board informed that Bliss GVS Healthcare, the Kenyan step down subsidiary of the Company has won an Annual Contract worth USD 38.76 million for a period of two years, from a consortium of leading insurance firms in Kenya for provision of in-patient and out-patient health care services for approximately 125000 principle members and their dependents.
The Board also approved the terms and conditions of the loan proposal of Rs 68 crore from IDFC/ ICBC Bank. The Board forwarded the loan proposal for review of audit committee.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app